DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

LinksClose Window

References

Adams S, Loi S, Toppmeyer DL. et al.
KEYNOTE‑086 cohort B: Pembrolizumab monotherapy for PD‑L1-positive, previously untreated, metastatic triple-negative breast cancer (mTNBC) [abstract].
In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5–9
San Antonio, TX Philadelphia (PA):
AACR. Cancer Res; 2018
78. Abstr. PF6-10

Download Bibliographical Data

Access:

We do not assume any responsibility for the contents of the web pages of other providers.